Navigation Links
Sensors for Medicine and Science, Inc. Names Dr. Paul Strumph as Chief Medical Officer
Date:2/2/2010

GERMANTOWN, Md., Feb. 2 /PRNewswire/ -- Sensors for Medicine and Science, Inc., a clinical-stage, medical device company pioneering breakthrough technology that could dramatically improve glucose monitoring for people with diabetes, today announced the appointment of Dr. Paul Strumph as the company's Chief Medical Officer.

Dr. Strumph was most recently Vice President and Chief Medical Officer of the Juvenile Diabetes Research Foundation.  At JDRF, his responsibilities included overseeing the clinical research portfolio and providing direction on clinical programs for JDRF's therapeutic areas, and providing guidance to JDRF on regulatory policy and therapeutic delivery issues, such as reimbursement and provider acceptance.  He was also a member of the four-person Research Senior Management Team that set Research Strategy, and validated Program Area strategies and execution.  

Prior to JDRF, Dr. Strumph held leadership positions in Clinical and Medical Affairs with Bristol-Myers Squibb & Co., Merck KGaA and GlaxoSmithKline, including clinical development of products in the therapeutic areas of diabetes, obesity and cardiovascular disease.  This experience included advancing therapeutic compounds through Phase I – IV clinical studies.  

Prior to entering industry, Dr. Strumph was a practicing endocrinologist and Clinical Assistant Professor at the UNC Department of Medicine.  He received his medical degree with distinction in research, from the University of Rochester School of Medicine and Dentistry and is a diplomate of boards in Internal Medicine, Endocrinology, Diabetes & Metabolism, Pediatrics, and Pediatric Endocrinology.

"I am delighted to join Sensors for Medicine and Science and contribute to the development of this groundbreaking technology," said Dr. Strumph.  "A long-term, continuous monitor that is sufficiently accurate to replace regular finger stick testing and does not require frequent calibration would be a major technical and clinical accomplishment.  Successful clinical development and commercialization of the Company's unique implanted glucose monitor could significantly improve the lives of people with diabetes."

"Paul is a great addition to our management team," said Marc Schneebaum, President & CEO of Sensors for Medicine and Science. "His distinguished reputation in the adult and pediatric diabetes communities and his extensive clinical and regulatory experience at all stages will be a perfect complement to our scientific team as we advance our long-term, implanted glucose monitor through clinical development and to commercialization. Moreover, his hands-on experience with glucose monitoring and insulin delivery technology should help us shape the product for optimal use by both people with diabetes and their physicians."

Sensors for Medicine and Science's lead product is a long-term, implanted continuous glucose monitor* based on its unique and proprietary sensor technology.  This product includes a miniaturized sensor and an external reader.  The sensor is inductively powered and remotely interrogated, so there is no battery on-board and no wires connecting the implanted sensor to the external reader.  As a result, after implantation, the sensor functions noninvasively, painlessly, automatically, and continuously.  Distinctive features include:

  • The sensor is designed to deliver accuracy that the Company believes could enable the product to replace regular finger stick monitoring.
  • The sensor is designed to deliver accurate results even when glucose levels are low, and when glucose levels are changing rapidly.  Accurate performance in these two situations is crucial to people with diabetes, and have proved to be particular challenges for competing devices.
  • The Company is targeting an implant period of up to one year, along with extended stability of calibration.

The Company plans to continue pilot clinical studies during 2010, and to initiate a pivotal clinical study in 2011.

About Sensors for Medicine and Science, Inc.

Sensors for Medicine and Science, Inc. is pioneering breakthrough technology that could dramatically improve glucose monitoring for people with diabetes.  The Company believes that its long-term, continuous glucose monitor technology has the potential to replace regular finger stick monitoring.  

Sensors for Medicine and Science, Inc. has also developed oxygen sensor technology, with potential applications in areas such as metabolic monitoring (weight management), respiratory and cardiac disease.  In addition, the Company sells its oxygen sensors as a component to original equipment manufacturers.

* NOTE: Sensors for Medicine and Science, Inc.'s glucose monitor is not available for sale and has not been approved by the U.S. Food and Drug Administration.

For more information about Sensors for Medicine and Science, Inc., please visit http://www.s4ms.com.

SOURCE Sensors for Medicine and Science, Inc.

RELATED LINKS
http://www.s4ms.com

'/>"/>

SOURCE Sensors for Medicine and Science, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World, All Comers Clinical Study
2. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
3. GSK Announces Open Innovation Strategy to Help Deliver New and Better Medicines for People Living in the Worlds Poorest Countries
4. European Medicines Agency (EMA) Waives Requirement to Test StemEx(R) in Paediatric Patients 17 Years of Age and Under
5. Medco Partners with AmeriCares to Rush Donated Medicines to Help Victims of the Haiti Earthquake
6. STELARA(TM) Shows Greater Efficacy Than Etanercept for Treatment of Moderate to Severe Plaque Psoriasis: Phase 3 Comparator Study Published in The New England Journal of Medicine
7. Asthmatx Pivotal Trial Manuscript for Bronchial Thermoplasty Published in the American Journal of Respiratory and Critical Care Medicine
8. Cardiac Science and Gust Bardy, MD Create Innovation Center for Primary Care Medicine
9. World Renowned Physician and Thought Leader Dr. Eric J. Topol to Highlight Digital Medicine Revolution at International CES 2010
10. Obama Plan Buckles Under Pharma Lobby; Plan to Import Low-Cost Medicines Derails
11. Senate Rejects Bulk Imports of Medicine from Canada, but Personal Importation Remains a Popular Option for U.S. Citizens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
Breaking Medicine Technology:
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room ... Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
Breaking Medicine News(10 mins):